Month: May 2025

May 26 2025

Uncategorized

People Living with Schizophrenia Are People First

by Clinical Editor

No Comments

Many people live bright and full lives while living with schizophrenia.

May 26 2025

Uncategorized

Should We Be Concerned About the Trends in Mental Illness?

by Clinical Editor

No Comments

Mental illness rates are rising, but not because of a crisis. They are a predictable result of stress, expanded criteria, and the COVID-19 pandemic. Community resilience is key.

May 25 2025

Uncategorized

Schizophrenia is severe yet treatable disease, say docs

by Clinical Editor

No Comments

Panaji: Rita (name changed), with a history of schizophrenia in the family, was a young girl when she was diagnosed with the chronic mental illness ten years ago. Medication brought...

May 25 2025

Uncategorized

Novel PDE10A Inhibitor for Acute Schizophrenia Safe, Effective in Large Phase 2 Trial

by Clinical Editor

No Comments

The novel PDE10A inhibitor CPL’36 offers a new mechanism of action and is both safe and effective for acute exacerbations of schizophrenia, new research suggests.

May 24 2025

Uncategorized

Schizophrenia Day: 5 things to know about the mental illness

by Clinical Editor

No Comments

World Schizophrenia Day is observed on May 24 to raise awareness about the mental illness and the stigma associated with it in our daily life …

May 24 2025

Uncategorized

A New Approach to Treating Brain Disorders

by Clinical Editor

No Comments

More than a billion people around the world suffer from mental disorders such as Alzheimer’s, Parkinson’s, ALS, Huntington’s, epilepsy, schizophrenia, depression, and anxiety. Brain diseases cost the …

May 23 2025

Uncategorized

Increased risk of psychopathology found in offspring of people with schizophrenia or bipolar disorder – Medical Xpress

by Clinical Editor

No Comments

Increased risk of psychopathology found in offspring of people with schizophrenia or bipolar disorder  Medical Xpress

May 23 2025

Uncategorized

Novel PDE10A Inhibitor for Acute Schizophrenia Safe, Effective in Large Phase 2 Study

by Clinical Editor

No Comments

The novel PDE10A inhibitor CPL’36 offers a new mechanism of action and is both safe and effective for acute exacerbations of schizophrenia, new research suggests.

May 22 2025

Uncategorized

Cauchi at ‘significant’ risk of relapsing into psychosis when discharged into doctor’s care, Bondi Junction inquest hears – The Guardian

by Clinical Editor

No Comments

Cauchi at ‘significant’ risk of relapsing into psychosis when discharged into doctor’s care, Bondi Junction inquest hears  The Guardian

May 22 2025

Uncategorized

Increased risk of psychopathology found in offspring of people with schizophrenia or bipolar disorder

by Clinical Editor

No Comments

A new study confirms that children of people with schizophrenia or bipolar disorder have a higher risk of developing psychopathology compared to children whose parents do not have these conditions.